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Effect of indomethacin on glomerular permselectivity and hemodynam-
ics in nephrotoxic serum nephritis. The present study was undertaken to
determine the effects of prostaglandin synthesis inhibition on glomeru-
lar hemodynamics in nephrotoxic serum nephritis and to elucidate the
mechanisms by which prostaglandin synthesis inhibition reduces pro-
teinuria in nephritic rats. Dextran sieving studies were performed
before and after intravenous administration of indomethacin to control
rats and to nephritic rats with heavy proteinuria. Indomethacin did not
significantly alter mean arterial pressure, glomerular filtration rate or
proteinuria in control rats nor were significant changes in dextran
sieving observed. By contrast, in nephritic rats indomethacin signifi-
cantly reduced glomerular filtration rate (2.58 0.50 vs. 1.39 0.27ml!
mm, P < 0.001), proteinuria (0.198 0.079 vs. 0.048 0.019 mg/mm,
P < 0.05) and filtration rate-corrected proteinuria (0.059 0.033 vs.
0.031 0.013 mg/mI GFR, P < 0.05). The fractional clearance of
neutral dextrans with molecular radii exceeding 42 A were elevated
above control values in nephritic rats (P < 0.05). After administration of
indomethacin, the fractional clearance of neutral dextrans uniformly
declined toward control values and remained elevated only for molec-
ular radii exceeding 54 A. Assessment of glomerular hemodynamics in
nephritic rats before and after indomethacin showed significant declines
in single nephron filtration rate (31.5 3.0 vs. 21.2 2.5 nI/mm, P <
0.02), glomerular plasma flow rate (99.5 6.7 vs. 68.5 7.8 nI/mm, P
< 0.05) and glomerular ultrafiltration coefficient (0.0430 0.0033 vs.
0.0339 0.0032nI sec . mm Hg, P <0.05). Indomethacin did not
significantly change these parameters in control rats. Utilizing a hetero-
porous mathematical model of the glomerular basement membrane, we
calculated that the proportion of glomerular filtrate permeating the
shunt pathway was elevated above control values in nephritis (0.33%
vs. 0.17%), but declined to a value of 0.21% after administration of
indomethacin. These data suggest that in nephrotoxic serum nephritis
prostaglandin inhibition reduces proteinuria by reducing filtration rate
and by improving glomerular size-selectivity via decreased utilization of
the shunt pathway.
Investigation of the mechanisms whereby inhibition of pros-
taglandin synthesis reduces proteinuria in experimental models
of glomerular injury and in the nephrotic syndrome in man has
yielded conflicting results. In many studies the ability of indo-
methacin to reduce the fractional clearance of protein has been
correlated with concomitant reductions in glomerular filtration
rate, renal blood flow and urinary excretion of PGE2 [1—7]. By
contrast, other investigators have dissociated reductions in
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proteinuria from decrements in filtration rate [8—13]. In studies
of glomerular disease in man, the fractional clearance of large
neutral dextrans, initially elevated above control values, has
been shown to decline after administration of indomethacin
[10]. On the other hand, no change in dextran sieving accom-
panied indomethacin-induced reductions in proteinuria in autol-
ogous immune complex nephritis [8]. Measurements of selec-
tivity of proteinuria after indomethacin have also failed to yield
consistent results [1, 2, 4, 8, 10].
The studies reported here were undertaken to determine the
effect of prostaglandin synthesis inhibition on glomerular hemo-
dynamics in nephrotoxic serum nephritis and to elucidate the
mechanism by which prostaglandin inhibition reduces protein-
uria in this model. Our data demonstrate an association be-
tween indomethacin-induced reductions in fractional protein
clearance and concomitant declines in glomerular hemodynam-
ics. Intravenous indomethacin reduced whole kidney and single
nephron filtration rate, glomerular plasma flow rate and glomer-
ular ultrafiltration coefficient without producing any change in
glomerular capillary pressure. Fractional clearances of large
neutral dextrans, elevated above control values in nephritis,
were also reduced after administration of indomethacin. The
fraction of glomerular filtrate permeating non-size selective
shunts in the glomerular basement membrane of nephritic rats
declined after indomethacin. These results suggest that pros-
taglandins play an important role in maintaining glomerular
plasma flow and GFR in NSN. Indomethacin reduces protein-
uria in nephrotoxic serum nephritis by reducing glomerular
filtration rate and by improving impaired glomerular size-
selectivity via decreased utilization of the shunt pathway.
Methods
Nephrotoxic serum nephritis was induced in 17 male Spra-
gue-Dawley rats initially weighing 310 15 grams as previously
described [14, 151. Rats were preimmunized with 10 mg goat
gamma globulin in Freund's complete adjuvant administered
subcutaneously. Four days later, goat gamma globulin with
antibody activity directed against rat glomerular basement
membrane was administered intravenously. The preparation of
this antiserum has been described previously [14]. Rats were
studied by dextran sieving or micropuncture techniques two
weeks after induction of nephritis. Fifteen normal rats initially
weighing 292 11 grams served as controls. Animals were fed
standard rat chow containing 23.4% protein and 0.4% sodium
51
52 Neugarten et a!: Indomethacin and nephritis
(Purina rat chow 5001, Ralston Purina, St. Louis, Missouri,
USA).
Nine nephntic and eight control rats underwent dextran
sieving studies as previously described [16]. In brief, rats were
anesthetized with mactin (100 mg/kg body wt) and placed on a
heat-regulated surgical table. Catheters were placed in the right
jugular vein, left ureter and left carotid and femoral arteries.
Blood pressure was monitored in the femoral artery utilizing a
Statham transducer (Statham Instruments, Inc., Oxnard, Cali-
fornia, USA) and a polygraph recorder (Grass Instrument Co.,
Quincy, Massachusetts, USA). Surgical volume losses were
replaced with rat plasma (1% of body weight). A bolus of C'4
inulin (8 MCi) and H3 polydisperse neutral dextrans (20 j.tCi;
New England Nuclear Corp., Boston, Massachusetts, USA)
was administered intravenously and followed by a maintenance
infusion of 0.9% NaCI containing H3 dextran (15 MCi/mI) and
C'4 inulin (6 jiCi/mi) at a rate of 3 mI/hr. Utilizing pulse-injected
FD and C green dye (FDCG) (Keystone Aniline and Chemical
Co., Chicago, Illinois, USA) the transit time through the
urinary catheter was determined. Blood was withdrawn from
the carotid artery catheter for 30 minutes via a withdrawal
pump (Harvard Apparatus, Natick, Massachusetts, USA) at a
rate of 0.5 m1130 mm. A thirty-minute urine collection was
begun after a period of time elapsed equal to the transit time.
After the first experimental period was concluded the volume of
blood removed by the constant withdrawal pump was replaced
with rat plasma. Dextran sieving studies were repeated after
intravenous administration of indomethacin (3 mg/kg as a
loading dose followed by 3 mg/kg/hr). We have previously
administered indomethacin in this dose to normal rats and
demonstrated a 95% reduction in urinary PGE2 excretion
(submitted for publication). Inulin clearance and urinary protein
excretion rates were determined for each period. Urinary
protein was measured with a colorimetric assay (Bio-Rad
Protein Assay, Blo-Rad Chemical Division, Richmond, Califor-
nia, USA) by methods previously described in detail [17].
Dextran sieving curves were constructed for each period
utilizing collected urine and blood samples. Separation of
dextrans in plasma and urine into narrow fractions of approxi-
mately 2 A was accomplished by gel permeation chromatogra-
phy with Ultrogel AcA34 and AcA44 (LKB Pharmaceuticals,
France) in a 1:1 mixture. Columns were calibrated with proteins
of known molecular size [16]. Eluted fractions were collected
with an automated fractionator (Buchler Instruments, Fort Lee,
New Jersey, USA). Following gel permeation chromatography
of plasma and urine, eluted fractions were assayed for tritiated
dextran by liquid scintillation counting (Beckman LS 7500,
Beckman Instrument Company, Irving, California, USA). The
void volume of the column was determined with blue dextran,
and the fractional volume available to the solute was calculated
as (Ve — V0)/(V — V0); where V0 is the void volume, Ve the
elution volume of the solute and V, the total volume of the
column. Stokes-Einstein radii for the individual dextran frac-
tions were calculated from Kay according to the method of
Granath and Kvist [181. 9ND for a given molecular radius was
determined from (U/P)extn/(U/P)inuiin. A dextran sieving
curve was constructed for each period and displayed graphi-
cally utilizing computer software.
Eight additional nephritic rats prepared exactly as above and
seven additional control rats were studied by micropuncture
techniques as previously described [19, 20]. Measurements
were made in each animal before and after administration of
indomethacin intravenously (3 mg/kg as a loading dose followed
by 3 mg/kglhr). For the performance of micropuncture, rats
were anesthetized with intraperitoneal mactin (100 mg/kg;
Promonta, Hamburg, FRG). After placement on a temperature
regulated heated surgical table, animals underwent tracheos-
tomy, tracheal intubation and cannulation of the left femoral
vein and left femoral artery. Mean arterial blood pressure was
continuously monitored via the femoral artery catheter. The left
kidney was exposed via a left paramedial incision, dissected
free of perirenal adipose tissue, placed in a lucite dish and
immobilized with cotton and silicon grease (Dow Corning
Corp., Midland, Michigan, USA). Warmed normal saline
bathed the exposed left kidney whose surface was illuminated
by a fiberoptic light system (Cole-Parmer, Chicago, Illinois,
USA). Body temperature was monitored via a rectal thermom-
eter (Yellow Springs Instrument Co., Yellow Springs, Ohio,
USA) and maintained between 37 to 38°C by adjustment of the
heat source. The left ureter was exposed and cannulated.
Animals received an intravenous loading dose of 80 Ci car-
boxyl inulin '4C (New England Nuclear Corp.) delivered in rat
plasma equal to 1% of body weight. This was followed by an
infusion of saline containing 20 CWml carboxyl inulin 14C per
ml at a rate of 0.05 mI/minute. Timed urine and blood collec-
tions were obtained for glomerular filtration rate (GFR) deter-
mination after a 60-minute equilibration period.
Timed tubular fluid samples were collected from early prox-
imal convoluted tubules identified by pulse injection of FDCG.
Free-flow hydraulic pressures were measured in proximal tu-
bules using a servo-nulling micropipet transducer system (WPI
Instruments, New Haven, Connecticut). Stopped-flow tubular
pressures were determined in early proximal convolutions by
insertion of a pressure measuring pipet proximal to an occluding
column of Sudan-black stained oil. Efferent arteriolar blood was
collected into heparin washed micropipets and transferred into
siliconized constant bore capillary tubes which were inserted
into microhematocrit tubes prior to centrifugation (Interna-
tional Equipment Co., Boston, Massachusetts, USA). The
hematocrit was read using an eyepiece micrometer.
Tubular fluid samples and plasma and urine samples were
transferred into liquid scintillation vials filled with Aquasol
(New England Nuclear Corp.) The activity of '4C was deter-
mined by liquid scintillation counting (Beckman Instruments,
Inc., Fullerton, California, USA). The following calculations
were made:
1. Single nephron glomerular filtration rate (SNGFR) =
(TFIP),,, x TF flow rate
2. Single nephron filtration fraction (SNFF) =
1 — (HctA(1 — HctE)/HctE( 1 — HCtA))
3. Glomerular plasma flow rate (QA) = SNGFRJSNFF
4. Glomerular blood flow rate (GBF) = QAI(i — HctA)
5. Glomerular capillary pressure (P0) = estopped-flow + TA
6. Mean transcapillary hydraulic pressure difference (P) =
GC —
7. Afferent arteriolar resistance (RA) = (iP — PGC)/GBF X
7.962 x 10'°
8. Efferent arteriolar protein concentration (CE) =
CA/(l — SNFF)
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MAP
mm Hg
GFR
mi/rnin
U,V
mg/mm
UPV/GFR
mg/mi GFR
Nephritis
Nephritis +
indometh-
acm
135 6
136 5
2.58 0.50
1.39 027b
0.198
0.048
0.079
0.019'
0.059 0.033
0.031 0.013a
Control
Control +
indometh-
acm
121 3
125 3
2.84 0.73
2.75 0.76
0.033
0.042
0.009
0.011
0.011 0.002
0.017 0.006
Systemic and efferent arteriolar colloid osmotic pressure were
determined from the systemic arterial plasma protein concen-
tration (CA) and SNFF utilizing equation 8 and the Landis-
Pappenheimer equation [21]. Glomerular ultrafiltration coeffi-
cient (Kf) was calculated as described by Deen, Robertson and
Brenner [22]. In each group unique values for Kf were calcu-
lated for rats in filtration disequilibrium (rr/LP < 0.95) and
pooled with minimum values calculated for rats in filtration
equilibrium to obtain average values in each group.
Urine samples from nephritic rats were analyzed for prosta-
glandin E2 by enzyme immunoassay techniques by methods
previously described in detail [23].
In order to further characterize glomerular size-selective
properties, we applied the heteroporous mathematical model of
Deen et al to our data [24]. This model assumes that the
glomerular capillary wall is comprised of a large population of
cylindrical pores of uniform radius and a smaller population of
transmembrane shunts which permit unhindered passage of
large neutral molecules such as gamma globulin or large molec-
ular weight dextrans. Utilizing this model, glomerular capillary
wall permselectivity can be characterized by intrinsic mem-
brane parameters: Kr, the ultrafiltration coefficient, w a pa-
rameter which determines the proportion of glomerular filtrate
passing through the shunt pathway and r0, the radius in Ang-
stroms of the selective pores. w0 and r0 were calculated utilizing
mean values for dextran sieving coefficients and mean values
for glomerular hemodynamic parameters measured in different
groups of rats, precluding statistical comparison.
Results are expressed as mean SEM. Statistical analyses
were performed utilizing Student's paired I-test, unpaired I-test
and Wilcoxon's rank sum test.
Results
Whole kidney and dextran sieving studies
Administration of indomethacin did not significantly alter
mean arterial pressure (MAP) in nephritic rats (Table 1). GFR
was significantly reduced after indomethacin (2.58 0.50 vs.
1.39 0.27 mllmin, P <0.001) as was urinary protein excretion
(0.198 0.079 mg/mm vs. 0.048 0.019 mg/mm, P < 0.001) and
filtration rate corrected proteinuria (0.059 0.033 vs. 0.031
0.013 mg/mI GFR, P < 0.05). Neither MAP, GFR nor protein-
uria were altered in control rats after administration of indo-
methacin (Table 1).
Shown in Figure 1 is a plot of sieving coefficients for dextrans
Dextran radius, A
Fig. 1. Sieving coefficients of polydisperse neutral dextrans in ne-
phritic and control rats before and during indomethacin infusion.
Sieving coefficients were elevated in nephritic rats compared to controls
for molecular radii exceeding 42 A, P < 0.05. Following cyclooxygen-
ase inhibition fractional clearances of neutral dextrans declined in
nephritic rats to values intermediate between those obtained prior to
indomethacin and those of normal controls and remained elevated only
for molecular radii exceeding 54 A, P < 0.05. Symbols are: (0)
NSN;(•) NSN-indomethacin; (0) control rats; (U) control-indo-
methacin.
with molecular radii ranging from 20 to 70 A as determined in
nephritic and control rats before and after indomethacin. The
fractional clearances of neutral dextrans with Einstein-Stokes
radii exceeding 42 A are significantly higher in nephritic rats as
compared to control rats (P < 0.05). After administration of
indomethacin, fractional clearances of neutral dextrans uni-
formly fell in nephritic rats and were significantly elevated
above control values only for dextrans exceeding 54 A in
radius. Indomethacin did not significantly alter dextran sieving
coefficients in control rats.
Glomerular hemodynamics
At the time of micropuncture, MAP did not differ between
control and nephritic rats (Table 2). Baseline Hct values were
similar in nephritic and control rats and were not significantly
changed after indomethacin (46 1 and 49 1 baseline vs. 46
1 and 50 1 post-indomethacin, NS). Filtration equilibrium
(Methods) was present in one nephritic and three control rats
prior to indomethacin, and in three nephritic and three control
rats after indomethacin. Baseline mean transcapillary hydraulic
pressure difference was elevated and glomerular ultrafiltration
coefficient depressed in nephritic as compared to control rats
(P: 42.6 0.6 vs. 37.9 0.8 mm Hg, P < 0.001; Kf: 0.0430
0.0033 vs. 0.0608 0.0054 nl. sec' mm Hg', P < 0.05). No
significant differences were observed between nephritic and
control rats in GFR (2.28 0.20 vs. 2.95 0.44 mllmin), single
nephron filtration rate (31.5 3.0 vs. 33.1 2.3 nllmin) or
glomerular plasma flow rate (99.5 6.7 vs. 115.7 9.4 nI/mm).
In nephritic rats, indomethacin reduced urinary PGE2 excretion
by 77%, from 23.5 15.9 pg/mm to 5.4 2.4 pg/mm (P < 0.05,
paired t-test), but had no effect on MAP (128 4 vs. 127 5
Table 1. Effect of indomethacin on renal function in nephritic and
control rats
1.0
0.1
0
C)C
0.01
0.001
a P < 0.05 vs. pre-indomethacin periodbP < 0.001 vs. pre-indomethacin period
20 30 40 50 60 70
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Table 2. Effect of indomethacin on glomerular hemodynamics in nephritic and control rats
MAP
mm Hg
GFR
mi/mm
SNGFR
ni/mm
PT
mm
Hg
PSF
nil
mm
P0 P
mm Hg SNFF
QA
ni/mm
CA C
gidi
A E
mm Hg
RA
1010
dyne
sec
cm5
Kf
ni
sec'
mm
Hg'
NSN
NSN +
indo
128
127
2.28
1.44
31.5
21.225b
10.7
11.0
31.6
31.8
53.2 42.6
±0.6
53.3 42.3
0.32
0.31
99.5
68.5
6.3 8.9
6.2 9.0
21.8 38.1
21.6 38.9
3.29
4.91
0.0430
0.0339
Control
Control +
indo
117
115
2.95
3.02
33.1
35.2
11.0
11.1
27.9
28.1
48.4 37.908d
48.7 37.6
0.28
0.28
115.7
126.1
6.0 8.4
6.0 8.4
20.2 34.7
20.5 34.3
2.57
2.20
0.0608
0.0653
a P < 0.05 vs. pre-indomethacin periodbP < 0.02 vs. pre-indomethacin period
P < 0.05 vs. NSN
"P < 0.001 vs. NSN
Table 3. Effect of indomethacin on the shunt pathway and pore
radius in nephritic and control rats
Pore
<o>
%
radius
A
Control 0.17 49.9
Control-indomethacin 0.17 50.5
Nephritis 0.33 50.4
Nephritis-indomethacin 0.21 51.8
mm Hg) or P (42.6 0.6 vs. 42.3 0.5 mm Hg). However,
significant reductions were observed in GFR (2.28 0.20 vs.
1.44 0.10 mI/mm, P < 0.02), SNGFR (31.5 3.0 vs. 21.2
2.5 ni/mm, P < 0.02), QA (99.5 6.7 vs. 68.5 7.8 nI/mm, P <
0.02) and in Kf (0.0430 0.0033 vs. 0.0339 0.0032
ni. sec' . mm Hg, P <0.05). Afferent arteriolar resistance
rose from 3.29 0.27 to 4.91 0.54 X 10'° dyne . sec . cm5,
P < 0.05. As shown in Table 2, indomethacin did not signifi-
cantly alter any of these parameters in control rats.
Mathematical analysis of basement membrane parameters
Using the heteroporous model of glomerular sieving pro-
posed by Deen et a! [241 we calculated <w>, the proportion of
glomerular filtrate passing through the shunt pathway and r0,
pore radius. As shown in Table 3, the calculated value of <ol>
was numerically greater in nephritic rats as compared to con-
trols (0.33% vs. 0.17%). In control rats <o> was not altered by
indomethacin. By contrast, in nephritic rats <o> fell to a value
of 0.21% after administration of indomethacin. Values for r0 are
also given in Table 3. As can be seen, there were no differences
between NSN vs. control, and indomethacin had no effect in
either group.
Discussion
The studies reported here were undertaken to elucidate the
glomerular hemodynamic response to indomethacin in nephro-
toxic serum nephritis and the mechanisms by which indometh-
acm reduces proteinuria in this model. Indomethacin reduced
whole kidney and single nephron filtration rate, glomerular
plasma flow rate and glomerular ultrafiltration coefficient. Gb-
merular hydraulic pressure was not altered. Filtration rate
declined by 46%, while proteinuria was reduced by 76%. Under
the same experimental conditions, fractional clearances of large
neutral dextrans, elevated above control value in nephntic rats,
were reduced after administration of indomethacin. The frac-
tion of gbomerular filtrate permeating non-size selective shunts
in the glomerular basement membrane declined after indometh-
acm, accounting for the observed improvement in glomerular
size selectivity. These results suggest that indomethacin re-
duces proteinuria in nephrotoxic serum nephritis by reducing
glomerular filtration rate and by partial restoration of gbomeru-
lar size-selectivity.
Mild nephrotoxic serum nephritis is accompanied by an
increase in P, which occurs presumably as an adaptation to a
reduced glomerular capillary ultrafiltration coefficient [25].
Loss of gbomerular polyanion underlies impairment in glomer-
ular charge selectivity [26]. Based on an analysis of dextran
sieving data by the model of glomerular permselectivity pro-
posed by Deen and coworkers [241, we have previously dem-
onstrated a population of non-selective shunts in the glomerular
basement membrane of nephritic rats [16]. These basement
membrane defects, nondiscriminatory with respect to size,
form a shunt pathway for the filtration of small as well as large,
otherwise impermeant macromolecules such as gamma globu-
lin. The decline in proteinuria and improvement in glomerular
size selectivity seen after indomethacin in nephritic rats is
explained by several factors. Both declines in I( and QA
contribute to the fall in GFR after indomethacin. The resulting
decline in convection accounts in large part for the fall in
proteinuria. However, while GFR fell 46%, proteinuria declined
76%. Reduced utilization of the shunt pathway accounted for
the observed reduction in 0 for larger neutral dextrans and
contributed to the decline in proteinuria. Although previous
studies of glomerular permselectivity in nephritis have cone-
bated reductions in P with declines in <cv>, P did not fall in
the present study. Long-term administration of indomethacin to
nephritic rats might reduce P, as postulated by other investi-
gators [7]. However, such a decline was not demonstrated in
our acute infusion studies despite an immediate effect on
glomerular size selectivity. Though failing to achieve statistical
significance, 9 for smaller neutral dextrans also declined in
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nephritic rats after indomethacin. A fall in QA is theoretically
expected to increase 0 for smaller dextrans, an effect opposite
to that observed. Since zP remained unchanged, the fall in 0 for
smaller dextrans after indomethacin is a result of the decreased
Kf.
It has been suggested that determination of SNFF from
measurements of femoral artery and efferent arteriole hemato-
crit values systematically exceed those derived from protein
measurements [27]. This may reflect methodologic artifact or
may reflect an actual difference between hematocrit values in
femoral artery and afferent arteriolar blood due to "plasma
skimming" [27]. On the other hand, others have failed to detect
disparities between measured peritubular capillary Hct and
protein-derived SNFF in normal hydropenic Munich-Wistar
rats [28]. In any case, Hct-derived SNFF determinations may
systematically underestimate QA but differences between
groups should be readily detected.
In experimental models of glomerular injury and in the
nephrotic syndrome in man, the ability of indomethacin to
reduce the fractional clearance of protein has been correlated
with concomitant reductions in filtration rate, renal blood flow
and urinary POE2 [1—6]. In patients with membranous nephrop-
athy and heavy proteinuria studied by Shemesh et a! [7], °ND
was elevated for dextrans of molecular radii 28 to 48 A; <to>
was increased three- to fourfold. Lowering of arterial pressure,
glomerular filtration rate and renal blood flow with indometh-
acm decreased fractional excretion of albumin and gamma
globulin due to a reduction in the proportion of glomerular
filtrate permeating the shunt pathway. It was hypothesized that
indomethacin-induced reductions in GC and QA resulted in a
decline in <w> and thus were responsible for the reduction in
proteinuria. However, GC could not be measured directly. In
addition, enhanced declines in renal hemodynamics correlating
with more pronounced reductions in fractional protein excre-
tion have been observed in proteinuric patients subjected to
sodium restriction with attenuation of these responses by salt
repletion [1—4]. It may be reasonably postulated from these data
that indomethacin-induced decrements in urinary protein excre-
tion are mediated by reduced renal hemodynamics. These
effects may be related, however, to volume status or sodium
balance.
Not all investigators, however, have confirmed these obser-
vations. Tiggeler, Hulme and Wijdeveld [10] documented an
impairment in glomerular size selectivity and elevated frac-
tional clearances of polyvinyl pyrrolidones of molecular radii
exceeding 40 A in patients with heavy proteinuria. Indometh-
acm reduced proteinuria and reduced the fractional clearance of
large polyvinyl pyrrolidones toward control values. However,
they found no correlation between decrements in filtration rate
and reductions in proteinuria and found selectivity of protein-
uria to be unchanged. Zoja et al [121 administered indomethacin
to rats with passive autologous immune complex nephropathy
and observed reductions in proteinuria and urinary excretion of
POE2, PGI2 and TXB2 in the absence of any change in filtration
rate. However, glomerular hemodynamics were not assessed.
Similar results were obtained by Kirschenbaum, Liebross and
Serros [8] in a model of autologous immune complex nephrop-
athy. They found no change in GFR, selectivity of proteinuria
or in the fractional clearance of neutral dextrans over the range
of molecular radii 18 to 44 A. It should be pointed out, however,
that the dextran probes utilized were not sufficiently large to
adequately evaluate glomerular size selectivity.
Glomerular hemodynamics after indomethacin have not pre-
viously been assessed in nephrotoxic serum nephritis. Our data
suggest that inhibition of vasodilatory prostaglandin synthesis
rather than inhibited synthesis of the vasoconstrictor thrombox-
ane is the major determinant of the hemodynamic response to
indomethacin 14 days after induction of nephrotoxic serum
nephritis. Whole kidney and single nephron GFR, glomerular
plasma flow rate and K declined accompanied by a rise in RA.
Gc remained constant requiring proportional increases in
afferent and efferent arteriolar resistances. Similar results have
been obtained in the remnant kidney where indomethacin
reduced SNGFR, QA and Kf due to proportional increases in
RA and RE while POC remained constant [29]. It is apparent
that, in contrast to the normal control rats, pre-glomerular
resistance, glomerular plasma flow, and K in the NSN rats are
under the influence of vasodilatory prostaglandins. Because of
this dependence, administration of indomethacin causes signif-
icant hemodynamic deterioration.
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